TapImmune Inc. Release: Status of Clinical Development Clarification

SEATTLE, March 4, 2011 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), wishes to provide a clarification to the Press Release issued on March 1, 2011 ‘TapImmune Closes $1.16 Million Funding’.

MORE ON THIS TOPIC